Current practice of state-of-the-art surgical coronary revascularization

SJ Head, M Milojevic, DP Taggart, JD Puskas - Circulation, 2017 - Am Heart Assoc
Coronary artery bypass grafting remains one of the most commonly performed major
surgeries, with well-established symptomatic and prognostic benefits in patients with …

Coronary artery disease and type 2 diabetes mellitus current treatment strategies and future perspective

R Naito, K Miyauchi - International heart journal, 2017 - jstage.jst.go.jp
Type 2 diabetes mellitus (T2DM) is a major risk factor of coronary artery diseases (CAD).
Clinical outcomes in CAD with T2DM are poor despite improvement in medications and …

Diretriz da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre intervenção coronária percutânea

F Feres, RA Costa, D Siqueira, JR Costa Jr… - Arquivos brasileiros de …, 2017 - SciELO Brasil
A Cardiologia Intervencionista tem experimentado extraordinário avanço nos últimos anos,
sendo atualmente o método de revascularização do miocárdio mais empregado em todos …

Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX …

R Cavalcante, Y Sotomi, M Mancone… - European heart …, 2017 - academic.oup.com
Aims To assess the impact of the SYNTAX scores I and II in outcomes after percutaneous
coronary intervention (PCI) and coronary artery bypass graft (CABG) for patients with …

Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?

A Kulik - Current opinion in cardiology, 2017 - journals.lww.com
Patients with multivessel coronary artery disease attain important QOL benefits following
revascularization with either PCI or CABG. Percutaneous treatments lead to a more rapid …

[HTML][HTML] Hospital surgical volumes and mortality after coronary artery bypass grafting: using international comparisons to determine a safe threshold

N Gutacker, K Bloor, R Cookson, CP Gale… - Health services …, 2017 - ncbi.nlm.nih.gov
Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using
International Comparisons to Determine a Safe Threshold - PMC Back to Top Skip to main …

Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: meta-analysis of randomized controlled trials

Z Fanari, A Malodiya, SA Weiss, S Hammami… - Cardiovascular …, 2017 - Elsevier
Background The potential benefit of long-term dual antiplatelet therapy (DAPT) for
secondary prevention of atherothrombotic events is unclear. Data from different randomized …

Outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention in patients aged 18–45 years with diabetes mellitus

Y Li, R Dong, K Hua, TS Liu, SY Zhou, N Zhou… - Chinese Medical …, 2017 - mednexus.org
Background: Debate on treatment for young patients with coronary artery disease still exists.
This study aimed to investigate the intermediate-and long-term outcomes between coronary …

[HTML][HTML] Percutaneous coronary intervention vs. cardiac surgery in diabetic patients. Where are we now and where should we be going?

G Kassimis, CV Bourantas, R Tushar… - Hellenic Journal of …, 2017 - Elsevier
Patients with diabetes mellitus are at increased risk of developing coronary artery disease
(CAD) and have an increased incidence of recurrent events following revascularization …

Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary …

M Milojevic, SJ Head, MJ Mack, FW Mohr… - European Journal of …, 2017 - academic.oup.com
OBJECTIVES To examine differences among participating countries in baseline
characteristics, clinical practice, medication strategies and outcomes of patients randomized …